Biology and genetics of adult male germ cell tumors.
暂无分享,去创建一个
[1] H. Leffers,et al. Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours , 2006, Virchows Archiv.
[2] Megan F. Cole,et al. Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells , 2006, Cell.
[3] James A. Cuff,et al. A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells , 2006, Cell.
[4] W. Voigt,et al. Loss of Oct-3/4 Expression in Embryonal Carcinoma Cells Is Associated with Induction of Cisplatin Resistance , 2006, Tumor Biology.
[5] Mariette Schrier,et al. A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors , 2006, Cell.
[6] Max S Wicha,et al. Cancer stem cells: an old idea--a paradigm shift. , 2006, Cancer research.
[7] M. Stratton,et al. Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. , 2006, Human molecular genetics.
[8] A. Olshen,et al. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. , 2006, Cancer research.
[9] Richard Lugg,et al. Sequence analysis of the protein kinase gene family in human testicular germ‐cell tumors of adolescents and adults , 2006, Genes, chromosomes & cancer.
[10] Yan Wang,et al. Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Pike,et al. The Y deletion gr/gr and susceptibility to testicular germ cell tumor. , 2005, American journal of human genetics.
[12] A. Clark,et al. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma , 2005, Cancer.
[13] Y. Mizutani,et al. KIT (c-kit oncogene product) pathway is constitutively activated in human testicular germ cell tumors. , 2005, Biochemical and biophysical research communications.
[14] Ethan Dmitrovsky,et al. Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. , 2005, Biochimica et biophysica acta.
[15] H. Schöler,et al. Developmental cell biology: Regulatory networks in embryo-derived pluripotent stem cells , 2005, Nature Reviews Molecular Cell Biology.
[16] M. Surani,et al. Blimp1 and the Emergence of the Germ Line during Development in the Mouse , 2005, Cell cycle.
[17] Megan F. Cole,et al. Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells , 2005, Cell.
[18] R. Huddart,et al. Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults. , 2005, Cancer research.
[19] M. Spinella,et al. A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embyronal carcinoma , 2005, Oncogene.
[20] Hans R Schöler,et al. Generating oocytes and sperm from embryonic stem cells. , 2005, Seminars in reproductive medicine.
[21] A. Olshen,et al. Gene expression-based classification of nonseminomatous male germ cell tumors , 2005, Oncogene.
[22] H. Leffers,et al. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours , 2005, Histopathology.
[23] E. Wardelmann,et al. Transcription factor AP‐2γ, a novel marker of gonocytes and seminomatous germ cell tumors , 2005, International journal of cancer.
[24] T. Bestor,et al. Eukaryotic cytosine methyltransferases. , 2005, Annual review of biochemistry.
[25] W. Ansorge,et al. Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours , 2005, British Journal of Cancer.
[26] L. Looijenga,et al. Testicular germ-cell tumours in a broader perspective , 2005, Nature Reviews Cancer.
[27] J. Clements,et al. Hypermethylation of the 5′ CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis , 2005, British Journal of Cancer.
[28] C. Allegrucci,et al. Epigenetics and the germline. , 2005, Reproduction.
[29] T. Ulbright. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues , 2005, Modern Pathology.
[30] R. Huddart,et al. Defining minimum genomic regions of imbalance involved in testicular germ cell tumors of adolescents and adults through genome wide microarray analysis of cDNA clones , 2004, Oncogene.
[31] P. Saunders,et al. Immunohistochemical Profiling of Germ Cells Within the Human Fetal Testis: Identification of Three Subpopulations , 2004, Biology of reproduction.
[32] Christian Schwager,et al. Embryonic Stem Cell-Like Features of Testicular Carcinoma in Situ Revealed by Genome-Wide Gene Expression Profiling , 2004, Cancer Research.
[33] T. Schlott,et al. Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation , 2004, British Journal of Cancer.
[34] C. Bokemeyer,et al. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells , 2004, The Journal of pathology.
[35] R. Day,et al. Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines , 2004, International journal of cancer.
[36] N. Skakkebaek,et al. Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads. , 2004, Human reproduction.
[37] F. Eyben. Chromosomes, genes, and development of testicular germ cell tumors , 2004 .
[38] A. Clark,et al. Human STELLAR, NANOG, and GDF3 Genes Are Expressed in Pluripotent Cells and Map to Chromosome 12p13, a Hotspot for Teratocarcinoma , 2004, Stem cells.
[39] Yusuke Nakamura,et al. Analysis of gene-expression profiles in testicular seminomas using a genome-wide cDNA microarray. , 2003, International journal of oncology.
[40] S. Fosså,et al. Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors. , 2003, Cancer research.
[41] J. Veltman,et al. 12p-Amplicon structure analysis in testicular germ cell tumors of adolescents and adults by array CGH , 2003, Oncogene.
[42] P. Donovan,et al. Turning germ cells into stem cells. , 2003, Current opinion in genetics & development.
[43] A. Mclaren,et al. Primordial germ cells in the mouse. , 2003, Developmental biology.
[44] H. Leffers,et al. High‐resolution comparative genomic hybridization detects extra chromosome arm 12p material in most cases of carcinoma in situ adjacent to overt germ cell tumors, but not before the invasive tumor development , 2003, Genes, chromosomes & cancer.
[45] J. Bacik,et al. Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[46] E. Vellenga,et al. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line , 2003, Cell Death and Differentiation.
[47] C. Bokemeyer,et al. Molecular determinants of treatment response in human germ cell tumors. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[48] E. Maher,et al. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours , 2003, Oncogene.
[49] A. Grothey,et al. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. , 2003, Cancer research.
[50] R. Lothe,et al. Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer , 2002, Oncogene.
[51] V. Reuter,et al. Characteristic promoter hypermethylation signatures in male germ cell tumors , 2002, Molecular Cancer.
[52] R. Kucherlapati,et al. Genomic and expression analysis of the 12p11-p12 amplicon using EST arrays identifies two novel amplified and overexpressed genes. , 2002, Cancer research.
[53] S. Lippard,et al. Testis-specific HMG-domain protein alters the responses of cells to cisplatin. , 2002, Journal of inorganic biochemistry.
[54] C. Plass,et al. Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors , 2002, Oncogene.
[55] R. Lothe,et al. New insights into testicular germ cell tumorigenesis from gene expression profiling. , 2002, Cancer research.
[56] K. Bussey,et al. SNRPN methylation patterns in germ cell tumors as a reflection of primordial germ cell development , 2001, Genes, chromosomes & cancer.
[57] J W Oosterhuis,et al. Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas , 2000, Oncogene.
[58] R. Chaganti,et al. Genetics and biology of adult human male germ cell tumors. , 2000, Cancer research.
[59] R. Kucherlapati,et al. A 3-Mb high-resolution BAC/PAC contig of 12q22 encompassing the 830-kb consensus minimal deletion in male germ cell tumors. , 1999, Genome research.
[60] P. Goss,et al. Chromosomal deletions occur in restricted regions of 5q in testicular germ cell cancer , 1999, Oncogene.
[61] V. Reuter,et al. Chromosomal amplification is associated with cisplatin resistance of human male germ cell tumors. , 1998, Cancer research.
[62] V. Reuter,et al. Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation , 1998, Oncogene.
[63] E. D. de Vries,et al. Differential effects of all-trans-retinoic acid, docosahexaenoic acid, and hexadecylphosphocholine on cisplatin-induced cytotoxicity and apoptosis in a cisplantin-sensitive and resistant human embryonal carcinoma cell line , 1998, Cancer Chemotherapy and Pharmacology.
[64] R. Chaganti,et al. A genetic perspective of male germ cell tumors. , 1998, Seminars in oncology.
[65] R. Chaganti,et al. The cytogenetic theory of the pathogenesis of human adult male germ cell tumors , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[66] P. Andrews. Teratocarcinomas and human embryology: Pluripotent human EC cell lines , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[67] V. Reuter,et al. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[68] V. Reuter,et al. Allelic loss and somatic differentiation in human male germ cell tumors. , 1994, Oncogene.
[69] E. Mariman,et al. Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. , 1994, Journal of the National Cancer Institute.
[70] R. Chaganti,et al. Origin of adult male mediastinal germ-cell tumours , 1994, The Lancet.
[71] P. Meltzer,et al. Molecular cytogenetic analysis of i(12p)‐negative human male germ cell tumors , 1993, Genes, chromosomes & cancer.
[72] B. Gallie,et al. Mutations of the p53 gene do not occur in testis cancer. , 1993, Cancer research.
[73] R. Lothe,et al. No germline TP53 mutations detected in familial and bilateral testicular cancer , 1993 .
[74] V. Reuter,et al. Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors. , 1992, Cancer research.
[75] V. Reuter,et al. Abnormalities of 2q: A common genetic link between rhabdomyosarcoma and hepatoblastoma? , 1991, Genes, chromosomes & cancer.
[76] J. Oosterhuis,et al. Cytogenetics of carcinoma in situ of the testis. , 1990, Cancer genetics and cytogenetics.
[77] M. Ladanyi,et al. Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors. , 1990, Journal of the National Cancer Institute.
[78] N. Skakkebaek,et al. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. , 1987, International journal of andrology.
[79] N. B. Atkin,et al. i(12p): specific chromosomal marker in seminoma and malignant teratoma of the testis? , 1983, Cancer genetics and cytogenetics.
[80] R. Pfundt,et al. Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene. , 2006, Cancer research.
[81] J. Gulcher,et al. A genome-wide study of allelic imbalance in human testicular germ cell tumors using microsatellite markers. , 2006, Cancer genetics and cytogenetics.
[82] P. Albers,et al. Gene Expression Profiling in Seminoma and Nonseminoma , 2005 .
[83] B. T. Teh,et al. UROLOGICAL ONCOLOGY: TESTIS CANCER AND ADVANCES IN ONCOLOGICAL THERAPY Gene Expression Profiling of Early- and Late-Relapse Nonseminomatous Germ Cell Tumor and Primitive Neuroectodermal Tumor of the Testis , 2005 .
[84] J. Thomson,et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells , 2004, Nature Biotechnology.
[85] R. Motzer,et al. Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.